High-communication polylactic acid microspheres as well as preparation method and application thereof
By treating high-dimensional polylactic acid scaffolds in high-low temperature solutions, the problems of uneven particle size of microspheres and lack of continuous microporous structure in the prior art are solved, and the size uniformity of spherical microspheres and the The high connectivity of the channel structure simplifies the process and reduces costs.
Patent Information
- Application Number
- CN202411023470.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-29
- Publication Date
- 2024-11-15
AI Technical Summary
The prior art is difficult to prepare polylactic acid microspheres with uniform particle size and continuous microporous structure, resulting in uneven drug release and limited function.
After 3D printing and molding of high-dimensional polylactic acid scaffolds, epiphyseal and elution are carried out in high and low temperature solutions. The dissolution and precipitation differences of surface polylactic acid molecules are used to form spherical microspheres, and microspheres are controlled through ultrasonic treatment and specific solvent systems. Ball size and channel structure.
The size uniformity of microspheres and the high connectivity of the channel structure are achieved, the process is simplified, the cost is reduced, and the preparation consistency and functionality of microspheres are improved.
Smart Images

Figure CN118955955A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of polylactic acid, and in particular to a high-connectivity polylactic acid microsphere and a preparation method and application thereof. Background Art
[0002] Microspheres refer to tiny spherical entities with a particle size range of 1 to 250 μm. Polylactic acid (PLA) is a suitable substrate for preparing microspheres because of its good biocompatibility and biodegradability, and the non-toxic and harmless degradation products, and has been approved by the US Food and Drug Administration (FDA).
[0003] Poly-L-lactic Acid (PLLA, CAS No.: 33135-50-1) is an important biodegradable polymer material. It is non-toxic, non-irritating, biodegradable and absorbable, high strength, good plasticity, and easy to process. The degradation cycle is 2 to 12 months, and the degradation cycle can be changed according to the addition of different modifiers. After injection, this degradable material decomposes into L-lactic acid in the body, which is exactly the same as the natural lactic acid in the human body. It can effectively stimulate the vitality of skin fibroblasts, stimulate the body's own collagen regeneration to fill the sunken parts, and improve facial wrinkles and skin quality. It can achieve volume contour changes and anti-aging all-round facial youth. And the effect of PLLA injection is different from other fillers. It shows therapeutic effects after weeks or months, and continues to work in human tissues for up to three years.
[0004] At present, most of the research on polylactic acid microspheres focuses on its use as a sustained-release carrier for drugs. It is widely used in biotechnology and medical fields such as small molecules, peptides or proteins, such as commercialized injection leuprorelin acetate microspheres and risperidone microspheres. The drug molecules in these drug-loaded microspheres can be dispersed and dissolved in the polylactic acid substrate by physical adsorption or chemical bonding, forming a tiny spherical entity with a particle size of microns. Polylactic acid microspheres with uniform particle size and excellent performance have significant advantages such as controllable drug release rate and time, extended drug action time, improved drug bioavailability, local release and targeting of drugs, and reduced drug toxicity and side effects on the whole body. However, high-value-added microspheres and microsphere products (such as micron needles, etc.) have very high requirements for particle size uniformity and preparation repeatability. Therefore, it is necessary to improve the method for preparing microspheres to obtain microspheres with uniform and controllable particle size.
[0005] The commonly used methods for preparing polymer sustained-release microspheres are mainly membrane emulsification method and emulsification solvent evaporation method. The membrane emulsification method is an emerging microsphere preparation method developed on the basis of the emulsification solvent evaporation method. It was first proposed by Japanese scientists Nakashima et al. in 1988. Its principle is to place the dispersed phase and the continuous phase on both sides of the microporous membrane respectively, give the dispersed phase a certain pressure, so that it passes through the microporous membrane and gathers into droplets on the membrane surface on the side of the continuous phase. The droplets are separated from the membrane under the action of their own gravity and the flushing of the continuous phase, forming uniform emulsion droplets, which solidify to form microspheres after the organic solvent in the emulsion evaporates. This method has excellent monodispersity. By selecting different membrane pore sizes and controlling the pressure applied to the dispersed phase through the membrane, microspheres with high particle size uniformity can be prepared; the preparation conditions are mild and suitable for encapsulating various drugs; the preparation process is simple and easy to control. However, the disadvantage of this method is that the emulsion passing through the microporous membrane during the preparation process is easy to cause membrane pore blockage and contamination; the hydrophilicity and hydrophobicity of the emulsion and the membrane will cause the dispersed phase to adhere to the membrane, thereby affecting the uniformity of the droplets; at the same time, the experimental equipment is complex and expensive, so the preparation and equipment maintenance costs are high. The emulsified solvent evaporation method is also called the liquid solvent evaporation method, which can be divided into four types: o / w, o / o, w / o / w, and w / o / o / o type emulsions. This method uses solvent evaporation to prepare drug-containing polylactic acid microspheres. The two immiscible phases are made into an emulsion by mechanical stirring or ultrasonic emulsification. The internal phase solvent is evaporated and removed, and the spherical material is precipitated and solidified into microspheres. The solvent of the inner dispersed phase must have a certain solubility and volatility in the outer continuous phase. Under slow stirring, the inner dispersed phase solvent continuously diffuses to the outer phase, is transported to the liquid surface and evaporates into the air. The extraction-evaporation-extraction process is repeated to precipitate the carrier material in the inner dispersed phase to form a capsule membrane, which wraps the drug until the microspheres are completely solidified. The factors that affect the properties of microspheres in this method are: drug solubility, organic solvent properties, organic solvent diffusion rate, temperature, polymer composition, polymer viscosity and drug loading. Since this method is a very complex process with many influencing factors, the quality is difficult to control. At present, most of them are produced in small batches in the laboratory, and there are certain difficulties in scaling up production.
[0006] For example, the preparation methods of polylactic acid disclosed in publication numbers CN116731386A and CN111298196A are complicated to operate and difficult to obtain microspheres of uniform size. In addition, the traditional method of preparing polylactic acid microspheres cannot directly obtain a continuous microporous structure, which greatly limits its function of transporting nutrients and efficiently stimulating physiological responses. Summary of the invention
[0007] Technical problems solved by the present invention:
[0008] It is used to solve the problem that the polylactic acid currently prepared has different sizes and cannot obtain a continuous microporous structure.
[0009] The technical solution adopted by the present invention is:
[0010] In view of the above technical problems, the purpose of the present invention is to provide a high-connectivity polylactic acid microsphere and its preparation method and application. Specifically, that is:
[0011] First, the present invention provides a method for preparing high-connectivity polylactic acid microspheres, wherein a polylactic acid scaffold is placed in a supersaturated solution of polylactic acid to carry out attachment to obtain a polylactic acid scaffold with attached microspheres; the polylactic acid scaffold with attached microspheres is eluted to obtain attached microspheres, and the attached microspheres are polylactic acid microspheres.
[0012] According to some optional embodiments, the size of the polylactic acid microspheres is 3 to 15 μm.
[0013] According to some optional embodiments, the polylactic acid stent is obtained by 3D printing of polylactic acid raw materials. That is, the polylactic acid raw materials are formed by 3D printing and then annealed. The molding temperature is 160-200°C; annealing: 60-100°C, 12-40h.
[0014] According to some optional embodiments, the solvent of the supersaturated solution of polylactic acid includes at least one of hexafluoroisopropanol, sodium hydroxide ethanol solution, 1,4-dioxane, and dichloromethane.
[0015] According to some optional embodiments, the epitaxial temperature is lower than the supersaturated solution temperature. The supersaturated solution temperature is 50-60°C, and the epitaxial temperature is 20-40°C.
[0016] According to some optional embodiments, the supersaturated solution is prepared by ultrasonic treatment for 20 to 60 minutes.
[0017] According to some optional embodiments, the attachment time is 15 to 60 minutes, preferably 20 to 40 minutes, and more preferably 30 to 40 minutes.
[0018] According to some optional embodiments, the polylactic acid scaffold with attached microspheres is eluted with anhydrous ethanol.
[0019] Second, the present invention provides polylactic acid microspheres obtained by the above-mentioned preparation method.
[0020] Third, the present invention provides an application of the aforementioned polylactic acid microspheres in facial filling and drug carrier.
[0021] The technical mechanism and beneficial effects adopted by the present invention are as follows:
[0022] The mechanism adopted by this technology is to utilize a high-dimensional polylactic acid scaffold as a heterogeneous nucleation site combined with the solubility difference between high and low temperature bulk solutions, with low-temperature automatic precipitation as the driving force. The high and low temperature difference and solubility parameters are regulated by partial dissolution of polylactic acid molecules on the surface of the polylactic acid scaffold and saturated precipitation of polylactic acid solutes in the solution. Due to the free spherical growth of the crystallized wafer, polylactic acid microspheres with uniform spherical size and high pore structure connectivity can be obtained.
[0023] Compared with the existing method of preparing PLLA crystals by phase separation, the present application utilizes the uniformity of single system solution and static solute precipitation, and the large specific surface area of 3D printed scaffolds to present a large number of heterogeneous nucleation sites of the bulk material in multi-dimensional space, and prepares microspheres with uniform size and controllable spherical shape. In comparison, the present method has a simple process and low cost. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1 This is a 3D bracket model diagram;
[0025] Figure 2 This is the SEM image of the polylactic acid microspheres prepared in Example 1 (scale 5 μm);
[0026] Figure 3 This is the SEM image of the polylactic acid microspheres prepared in Example 2 (scale 20 μm);
[0027] Figure 4 This is the SEM image of the polylactic acid microspheres prepared in Example 3 (scale 10 μm);
[0028] Figure 5 This is the SEM image of the polylactic acid microspheres prepared in Example 4 (scale 5 μm);
[0029] Figure 6 This is the SEM image of the polylactic acid microspheres prepared in Example 5 (scale: 10 μm). DETAILED DESCRIPTION
[0030] In order to make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the technical scheme in the embodiments of the present invention will be described clearly and completely below. If the specific conditions are not specified in the embodiments, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.
[0031] Example 1
[0032] This embodiment provides a method for preparing polylactic acid microspheres, comprising the following steps:
[0033] (1) The polylactic acid scaffold was printed by 180°C fused deposition method, where the diameter of the scaffold wire was 0.6 mm, the scaffold shape was usually multi-layer concentric cylinders (8 layers), and the interlayer spacing was 0.1. The 3D printed scaffold model was as follows: Figure 1 The prepared scaffold was annealed at 80°C for 4 hours to obtain an epitaxial scaffold template with a stable aggregated structure.
[0034] (2) Place the polylactic acid particles into a hexafluoroisopropanol solution (excess polylactic acid particles to ensure that there are undissolved polylactic acid particles in the system), and ultrasonicate at 60°C for 30 minutes to obtain a supersaturated solution. Place the epitaxial scaffold template in (1) into the supersaturated solution, place the beaker in a 40°C water bath and let it sit for 40 minutes, remove the scaffold, and use anhydrous ethanol for ultrasonic washing and desorption, followed by dehydration, filtration, and freeze-drying. The polylactic acid microspheres prepared by the above method were observed, and the results were as follows: Figure 2 As shown. Figure 2 It can be seen that the prepared linked microspheres are 5 μm in size, have interconnected micropores and are relatively uniform in size.
[0035] Example 2
[0036] This embodiment provides a method for preparing polylactic acid microspheres, comprising the following steps:
[0037] (1) The polylactic acid scaffold was printed by 180°C fused deposition method, where the diameter of the scaffold wire was 0.6 mm, the scaffold shape was usually multi-layer concentric cylinders (8 layers), and the interlayer spacing was 0.1. The 3D printed scaffold model was as follows: Figure 1 The prepared scaffold was annealed at 80°C for 4 hours to obtain an epitaxial scaffold template with a stable aggregated structure.
[0038] (2) Put the polylactic acid pellets into an excess of hexafluoroisopropanol solution and ultrasonicate at 50°C for 30 minutes to obtain a supersaturated solution. Put the epitaxial scaffold template in (1) into the supersaturated solution, put the beaker into a 40°C water bath and let it attach for 40 minutes, take out the scaffold, and ultrasonicate it with anhydrous ethanol for desorption, then dehydrate, filter and freeze-dry. The polylactic acid microspheres prepared by the above method were observed, and the results were as follows: Figure 3 As shown. Figure 3 It can be seen that microspheres with a size of 12 μm, interconnected micropores and uniform size were prepared.
[0039] Example 3
[0040] This embodiment provides a method for preparing polylactic acid microspheres, comprising the following steps:
[0041] (1) The polylactic acid scaffold was printed by 180°C fused deposition method, where the diameter of the scaffold wire was 0.6 mm, the scaffold shape was usually multi-layer concentric cylinders (8 layers), and the interlayer spacing was 0.1. The 3D printed scaffold model was as follows: Figure 1 The prepared scaffold was annealed at 80°C for 4 hours to obtain an epitaxial scaffold template with a stable aggregated structure.
[0042] (2) Put the polylactic acid pellets into a xylene solution and ultrasonicate at 50°C for 30 minutes to obtain a supersaturated solution. Put the epitaxial scaffold template in (1) into the supersaturated solution, put the beaker into a 30°C water bath and let it sit for 40 minutes. Take out the scaffold, wash it with anhydrous ethanol for ultrasonic desorption, and then dehydrate, filter and freeze-dry. The polylactic acid microspheres prepared by the above method were observed, and the results were as follows: Figure 4 As shown. Figure 4 It can be seen that microspheres with a size of 8 μm, interconnected micropores and uniform size were prepared.
[0043] Example 4
[0044] This embodiment provides a method for preparing polylactic acid microspheres, comprising the following steps:
[0045] (1) The polylactic acid scaffold was printed by 180°C fused deposition method, where the diameter of the scaffold wire was 0.6 mm, the scaffold shape was usually multi-layer concentric cylinders (8 layers), and the interlayer spacing was 0.1. The 3D printed scaffold model was as follows: Figure 1 The prepared scaffold was annealed at 80°C for 4 hours to obtain an epitaxial scaffold template with a stable aggregated structure.
[0046] Polylactic acid pellets were placed in a sodium hydroxide ethanol aqueous solution (0.05 mol / L, V 乙醇 :V 水 =1:1), ultrasonic at 50℃ for 30min to obtain a supersaturated solution. The template of the epitaxial scaffold in (1) was placed in the supersaturated solution, and the beaker was placed in a 40℃ water bath for 40min. The scaffold was taken out, ultrasonically washed with anhydrous ethanol for desorption, and then dehydrated, filtered, and freeze-dried. The polylactic acid microspheres prepared by the above method were observed, and the results were as follows Figure 5 As shown. Figure 5 It can be seen that microspheres with a size of 5 μm, interconnected micropores and uniform size were prepared.
[0047] Example 5
[0048] This embodiment provides a method for preparing polylactic acid microspheres, comprising the following steps:
[0049] (1) The polylactic acid scaffold was printed by 180°C fused deposition method, where the diameter of the scaffold wire was 0.6 mm, the scaffold shape was usually multi-layer concentric cylinders (8 layers), and the interlayer spacing was 0.1. The 3D printed scaffold model was as follows: Figure 1 The prepared scaffold was annealed at 80°C for 4 hours to obtain an epitaxial scaffold template with a stable aggregated structure.
[0050] (2) Put the polylactic acid pellets into 1,4-dioxane solution and ultrasonicate at 50℃ for 30min to obtain a supersaturated solution. Put the annealed template support into the supersaturated solution, put the beaker into a 40℃ water bath for 40min, take out the support, ultrasonicate with anhydrous ethanol for desorption, and then dehydrate, filter and freeze-dry. The polylactic acid microspheres prepared by the above method were observed, and the results were as follows: Figure 6 As shown. Figure 6 It can be seen that microspheres with a size of 6 μm, interconnected micropores and uniform size were prepared.
[0051] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A method for preparing high-connectivity polylactic acid microspheres, It is characterized in that Placing the polylactic acid scaffold in a supersaturated solution of polylactic acid for attachment to obtain a polylactic acid scaffold with attached microspheres; The polylactic acid scaffold of the attached microspheres is eluted to obtain the attached microspheres, which are polylactic acid microspheres.
2. The method for preparing high-connectivity polylactic acid microspheres according to claim 1, It is characterized in that The size of the polylactic acid microspheres is 3 to 15 μm.
3. The method for preparing high-connectivity polylactic acid microspheres according to claim 1, It is characterized in that The polylactic acid scaffold is obtained by 3D printing the polylactic acid raw material and then annealing it.
4. The method for preparing high-connectivity polylactic acid microspheres according to claim 3, It is characterized in that The molding temperature is 160-200°C; annealing: 60-100°C, 12-40h.
5. The method for preparing high-connectivity polylactic acid microspheres according to any one of claims 1 to 4, It is characterized in that The solvent of the polylactic acid supersaturated solution includes at least one of hexafluoroisopropanol, sodium hydroxide ethanol solution, 1,4-dioxane and dichloromethane.
6. The method for preparing high-connectivity polylactic acid microspheres according to any one of claims 1 to 4, It is characterized in that The epiphytic temperature is lower than the supersaturated solution temperature.
7. The method for preparing high-connectivity polylactic acid microspheres according to claim 6, It is characterized in that The temperature of the supersaturated solution is 50-60°C, and the epiphytic temperature is 20-40°C.
8. The method for preparing high-connectivity polylactic acid microspheres according to any one of claims 1 to 4, It is characterized in that The polylactic acid scaffold with attached microspheres was eluted with anhydrous ethanol.
9. Polylactic acid microspheres obtained by the preparation method according to any one of claims 1 to 8.
10. Use of the polylactic acid microspheres as claimed in claim 9 in facial filling and drug carrier.
